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Abstract
The coexistence of systemic lupus erythematosus (SLE) in patients with congenital human
immunodeficiency virus (HIV) infection is rare. This is a case report of a child diagnosed with SLE
at nine years of age. She initially did well on non-steroidal anti-inflammatory agents,
hydroxychloroquine, and steroids. She then discontinued her anti-lupus medications and was lost
to follow-up. At 13 years of age, her lupus symptoms had resolved and she presented with
intermittent fevers, cachexia, myalgias, arthralgias, and respiratory symptoms. Through subsequent
investigations, the patient was ultimately diagnosed with congenitally acquired immunodeficiency
syndrome (AIDS).
Introduction
The coexistence of HIV in patients with lupus is extremely
rare, especially in the pediatric population. Case reports
generally describe patients with HIV who subsequently
develop rheumatologic complaints. In children, there
have only been five reported pediatric cases of SLE and
HIV [1-4]. In all of five, the children had known congeni-
tal HIV and then developed SLE. In four of those cases, the
child developed lupus nephritis, but no other clinical
manifestation of SLE [1-3]. The fifth was a case report of
lupus vasculitis without nephritis in a child with congen-
ital HIV [4]. The case we are presenting is exceedingly rare
among pediatric cases and we could not find a similar one
in the literature. Our patient first presented with SLE and
subsequently showed the manifestations of congenital
human immunodeficiency syndrome.
Case presentation
Patient was a 9 year old African American female who pre-
sented with fevers, polyarthritis, and morning stiffness.
She had no rash or significant adenopathy. Her height was
at the 25th percentile for age and her weight was just below
the 50th  percentile. Laboratory investigations revealed
WBC = 2,800 cells/mm3 (58% neutrophils, 38% lym-
phocytes), hemoglobin = 10.4 g/dL, platelets = 167,000/
mm3, erythrocyte sedimentation rate(ESR) = 56 mm/h,
ANA titer = 1:1280, C4 complement <10 mg/dl, and anti-
double stranded DNA (dsDNA) = 1051 IU/ml. Urinalysis
was within normal limits. She was diagnosed with SLE
and treated with prednisone, naproxen, and hydroxy-
choloroquine Over the next ten months, the prednisone
was tapered and discontinued. The naproxen was later
changed to rofecoxib and she did well on a combination
rofecoxib and hydroxychloroquine for two years. She was
then lost to follow-up for 13 months and did not take her
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medications. She then returned, complaining of arthral-
gias. She had no arthritis on exam and laboratory studies
showed anemia with a hemoglobin of 9.9, WBC = 2.1
cells/mm3  (51%neutrophils, 23% lymphocytes, 21%
monocytes and 5% basophils) and ESR = 56 mm/h. Her
dsDNA was now negative and complements were normal.
She developed a fungal pharyngitis which resolved with
fluconazole. She was referred to an immunologist, but
never went. She was then brought into her pediatrician's
office complaining of a nonproductive cough for three
months. She described shortness of breath, left pleuritic
chest pain, fevers to 101°F, chills, and night sweats for
one week. There was a documented five-pound uninten-
tional weight loss. She denied any joint pain, rashes, pal-
pitations, diaphoresis, change in bowel patterns, or
urinary symptoms. She also denied any history of sick
contacts, blood transfusions, recent travel, sexual activity,
or abuse. She was admitted to the hospital for further
investigations.
Past medical history revealed that patient was born full-
term at 5 pounds, 9 ounces to a 25 year old mother who
smoked throughout pregnancy. She was discharged from
the nursery without complications. There were no other
past medical issues.
Family history, given by the maternal grandmother, was
notable for her mother reportedly dying suddenly, three
months prior to admission due to a "heart attack." Her
father reportedly died several years prior from a motor
vehicle accident. There was no family history of any rheu-
matologic disorders. Further history later obtained from
grandfather, revealed that both biological parents had
actually died of complications of HIV, and the mother was
diagnosed with HIV when the patient was four year old.
She was not checked for HIV during pregnancy.
Social History
The patient lived in an inner city apartment with a
brother, two sisters and maternal grandmother. She
denied any use of illicit substances, alcohol, or tobacco.
Physical examination revealed an African-American
female who was cachectic and pale, but alert, and in no
acute distress. Vital signs showed a temperature of 99.2F,
respiratory rate = 21 breaths per minute, saturating 99%
on room air. Heart rate was 114 beats per minute and
blood pressure 86/63 mmHg. Weight was at the 5th per-
centile for age and height was 50th – 75th percentile. Signif-
icant findings included temporal muscle wasting and
scarred tympanic membranes. She had enlarged (2–3
cm), non-tender nodes in the upper cervical, axillary, and
inguinal regions. Respiratory exam revealed a productive
cough and fair air entry with scattered rales, and left cos-
tochondral tenderness. Abdomen was benign with no
organomegaly. Genital exam revealed Tanner stage III
breasts and Tanner stage II pubic hair. She had no rashes,
joint swelling, or limitation of movement.
Laboratory studies revealed: WBC = 9700 cells/mm3,
hemoglobin = 9.6 g/dl, MCV = 75, RDW = 22.6, reticulo-
cytes = 0.8%, and ESR = 191 mm/hr. HIV ELISA was
repeatedly positive; HIV Western Blot positive, Viral Load
= 516,527, CD4/CD8 = 0.06, CD4 Helper = 1.9, CD8 =
30.1. Her CH50 = 104 mg/dl, C3 = 178 mg/dl, C4 = 29
mgldl, dsDNA negative. Ear canal culture: heavy growth of
Staph aureus. Blood culture was negative. Anergy panel
was non-reactive.
Chest radiograph revealed extensive left lower lobe infil-
trate. Chest CT Scan showed left lower lobe consolidation
with no pleural effusion. Bronchoscopy revealed mild-
moderate edema with moderate secretions in left bron-
chus.
The patient was treated with antibiotics, including
Bactrim prophylaxis for pneumocystic carini. After one
week she was discharged from hospital with the diagnoses
of AIDS and Mycobacterium Avium Complex (MAC)
infections. On follow up with the HIV clinic, she was
placed on antiretroviral therapy and continued MAC med-
ication. Her CD4 helper dropped to 0.40 × 103. She died
two years later from HIV cardiomyopathy.
Discussion
The prevalence of lupus in the adult HIV population is
low. From 1988–2002 only 30 cases were reported, and
many did not meet four of the ACR criteria [5]. Most cases
were patients with long-standing HIV infection who then
presented with manifestations of SLE. There have been
four reported pediatric cases in which children with con-
genital HIV, ages 7 to 37 months, developed lupus nephri-
tis, but no other clinical manifestations of SLE [1-3]. There
has been one pediatric case report of a 42 month old
patient with AIDS and who later developed cutaneous
vasculitis and met criteria for SLE [4]. This is the first
reported case of a child with congenital HIV who first pre-
sented with multiple manifestations of lupus, and then
developed AIDS years later.
It is not well understood why it is so rare to see both SLE
and HIV in patients simultaneously. It has been suggested
that demographic factors may be important since SLE is
much more common in women, and HIV had been more
common in homosexual men [6]. However, now that HIV
is affecting more and more women, we would expect to
see a rise in patients with both diseases, and that has not
been reported. It has also been suggested that the marked
antibody production in SLE is protective against HIVPediatric Rheumatology 2008, 6:7 http://www.ped-rheum.com/content/6/1/7
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infection. This was first suggested by Wallace in 1991,
when he noted the absence of HIV infection in lupus
patients who received unscreened blood between 1978
and 1983 [7].
Hydroxychloroquine (HCQ) is often used to treat SLE and
it may protect against HIV infection. HCQ has been used
in combination with other antiviral medications in a few
small studies and seems to help reduce the viral load in
HIV. [8] Chloroquine and HCQ inhibit the posttransla-
tional modification of gp120 in T cells and monocytes [9].
They increase endosomal pH and therefore inhibit pH
dependent steps required for viral replication[10]. It is
therefore possible that HCQ helped to slow down the
AIDS manifestations in our patient. HCQ was started
when she was diagnosed with SLE and discontinued 3
years later. Soon after she stopped taking the HCQ, her
AIDS symptoms began.
On the other hand, there is increasing evidence that
viruses may play a major role in the development of many
rheumatologic diseases. Epstein-Barr virus, parvovirus,
hepatitis, and retroviruses are potential triggers for various
rheumatic disorders, including lupus[11]. In HIV, glyco-
protein 120(gp 120) plays an important role in immune
dysregulation. It can bind to CD4 on T cells to cause T cell
activation and decreased self-tolerance. It can also bind to
CD4 on B cells and cause polyclonal B cell activation [12].
It is possible that HIV infection might contribute to the
development of SLE in patients such as ours.
AIDS and SLE are similar in many ways. They both can
present with a combination of symptoms including
fevers, rashes, weight loss, joint pain, anemia, leukopenia,
proteinuria, vasculitis, etc. Both disorders can have signif-
icant T and B cell dysfunction with polyclonal B cell acti-
vation and T cell activation. Many patients thought to
have lupus are screened for HIV for this reason. Both dis-
eases can have a positive ANA, but in HIV the titer is gen-
erally low [13]. Anti-dsDNA antibodies are not usually
seen in patients with HIV and are thought to be specific
for lupus. Complements are also generally normal in HIV.
Our patient had an ANA titer of 1:1280, an anti-dsDNA of
1051 and depressed C4 levels at initial presentation.
In summary, we present a 9-year-old female with SLE that
was well controlled on hydroxychloroquine and
rofecoxib. After being lost to follow-up and discontinuing
her medications, she presented with fungal pharyngitis
and then pneumonia and MAC infection. She tested pos-
itive for HIV and had a very low CD4 count. At that time
she had no further complaints of arthritis and her lupus
serologies had normalized. Immunosuppression second-
ary to HIV infection likely mitigated her manifestations of
SLE.
We reviewed the literature and found only five other pedi-
atric cases of congenital HIV and lupus. Our case is unique
in that our patient had documented SLE and then devel-
oped manifestations of HIV. Therefore, in children with
SLE and infections that seem unusual for the amount of
immunosuppression due to the underlying rheumato-
logic disease or its treatment, the differential diagnosis
must include congenital or acquired immunodeficiencies.
Clinicians should not hesitate to test for HIV when appro-
priate, regardless of any known risk factors.
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